Parametric Portfolio Associates’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.64M Sell
32,298
-11,435
-26% -$505K ﹤0.01% 2526
2021
Q4
$2.07M Sell
43,733
-6,157
-12% -$242K ﹤0.01% 2418
2021
Q3
$1.64M Sell
49,890
-7,858
-14% -$442K ﹤0.01% 2542
2021
Q2
$3.65M Buy
57,748
+26,858
+87% +$1.39M ﹤0.01% 2068
2021
Q1
$1.32M Sell
30,890
-21,903
-41% -$1.04M ﹤0.01% 3027
2020
Q4
$3.02M Buy
52,793
+31,167
+144% +$1.32M ﹤0.01% 2399
2020
Q3
$652K Sell
21,626
-9,178
-30% -$274K ﹤0.01% 3138
2020
Q2
$1.01M Buy
30,804
+20,854
+210% +$670K ﹤0.01% 2918
2020
Q1
$267K Buy
9,950
+409
+4% +$14.5K ﹤0.01% 3435
2019
Q4
$292K Sell
9,541
-759
-7% -$21K ﹤0.01% 3575
2019
Q3
$248K Buy
+10,300
New +$283K ﹤0.01% 3626

Other funds holding APLS